Scandion is a biotechnology company. The company develops pharmaceuticals for the treatment of cancer containing drug-resistant cell clones. The leading product of the company, SCO-101, has shown to improve the effect of certain standard cancer treatments during preclinical studies. The head office of the company is located in Copenhagen.

Quotes for Scandion Oncology

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Bo Rode Hansen

Chairperson of the Board

  • Peter Høngaard

Board

  • Annie Rasmussen
  • Bo Hansen
  • Carl Borrebäck
  • Christian Vinding Thomsen
  • Jørgen Bardenfleth
  • Thomas Feldthus

Videos

Largest Owners

Name Capital % Votes % Date
Fenja Capital Partners A/S 12,70 12,70 2024-08-28
Nordnet Pensionsförsäkring 12,16 12,16 2024-08-28
Avanza Pension 6,49 6,49 2024-08-28